Imidacloprid, Thiacloprid, and Their Imine Derivatives Up-Regulate the α4β2 Nicotinic Acetylcholine Receptor in M10 Cells
- 1 November 2000
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 169 (1), 114-120
- https://doi.org/10.1006/taap.2000.9057
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Upregulation of Surface α4β2 Nicotinic Receptors Is Initiated by Receptor Desensitization after Chronic Exposure to NicotineJournal of Neuroscience, 1999
- Novel and Potent 6-Chloro-3-pyridinyl Ligands for the α4β2 Neuronal Nicotinic Acetylcholine ReceptorJournal of Medicinal Chemistry, 1999
- Effects of the α subunit on imidacloprid sensitivity of recombinant nicotinic acetylcholine receptorsBritish Journal of Pharmacology, 1998
- Regulation of Human α4β2 Neuronal Nicotinic Acetylcholine Receptors by Cholinergic Channel Ligands and Second Messenger PathwaysMolecular Pharmacology, 1997
- Chronic Nicotine Treatment Up-Regulates α3 and α7 Acetylcholine Receptor Subtypes Expressed by the Human Neuroblastoma Cell Line SH-SY5YMolecular Pharmacology, 1997
- Post-translational regulation of neuronal acetylcholine receptors stably expressed in a mouse fibroblast cell lineJournal of Neurobiology, 1996
- Phosphorylation of rat brain nicotinic acetylcholine receptor by cAMP-dependent protein kinase in vitroMolecular Brain Research, 1993
- Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatmentJournal of Neuroscience, 1992
- Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human BrainJournal of Neurochemistry, 1988
- In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic DrugsJournal of Neurochemistry, 1985